News tagged with pancreatic tumor
Scientist proves potential of new nanoparticle design for cancer therapy
A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, Kenan Distinguished Professor ...
Nanotechnology / Bio & Medicine
Sep 20, 2011 |
5 / 5 (2) |
0
Malaria drug slows pancreatic cancer growth in mouse models
Dana-Farber Cancer Institute scientists report they have shrunk or slowed the growth of notoriously resistant pancreatic tumors in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis.
Mar 15, 2011 |
not rated yet |
1
|
Researchers find possible new treatment strategies for pancreatic cancer
New University of Georgia research has identified a protein that can be modified to improve the effectiveness of one of the most common drugs used to treat pancreatic cancer.
Mar 03, 2011 |
not rated yet |
0
Scientists crack genetic code for form of pancreatic cancer
Scientists at Johns Hopkins have deciphered the genetic code for a type of pancreatic cancer, called neuroendocrine or islet cell tumors. The work, described online in the Jan. 20 issue of Science Express, shows that patien ...
Jan 21, 2011 |
4.2 / 5 (5) |
0
|
Missing molecules hold promise of therapy for pancreatic cancer
By determining what goes missing in human cells when the gene that is most commonly mutated in pancreatic cancer gets turned on, Johns Hopkins scientists have discovered a potential strategy for therapy.
Dec 15, 2010 |
4.5 / 5 (2) |
0
|
Gefitinib may have chemopreventive benefits in pancreatic cancer
Gefitinib may be a promising chemoprevention agent for pancreatic cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Nov 08, 2010 |
5 / 5 (2) |
0
UNC team discovers promising target for new pancreatic cancer treatments
One of the most frustrating problems faced by doctors who treat pancreatic cancer is the lack of effective therapeutic options. More than 38,000 people in the United States die of the disease each year, and new drugs and ...
Nov 05, 2010 |
5 / 5 (1) |
0
Surprise finding: Pancreatic cancers progress to lethal stage slowly
Pancreatic tumors are one of the most lethal cancers, with fewer than five percent of patients surviving five years after diagnosis. But a new study that peers deeply into the genetics of pancreatic cancer presents a bit ...
Oct 27, 2010 |
4.2 / 5 (5) |
0
|
Functional magnetic resonance imaging to evaluate pancreatic cancer
In an effort to develop new therapies for pancreatic cancer, models of this disease must be created and characterized. A recent study from United States found that advanced magnetic resonance imaging methods could be used ...
Jul 30, 2010 |
5 / 5 (1) |
0
Circulating tumor cells correlate with poorer survival in pancreatic cancer patients
Fox Chase Cancer Center investigators find that pancreatic cancer patients who have circulating tumor cells tend to have worse outcomes than patients without circulating tumor cells. Additionally, the team has uncovered evidence ...
May 28, 2010 |
3.5 / 5 (2) |
1
Molecular marker could help spot pancreatic cancer early
Researchers at the University of North Carolina at Chapel Hill School of Medicine have identified a molecular marker of pancreatic cancer that may help spot the disease at its earliest stages, when it can ...
Apr 26, 2010 |
not rated yet |
0
Solid-pseudopapillary neoplasm of the pancreas or pancreatic endocrine tumor?
A research team from China investigated differential points of solid-pseudopapillary neoplasm (SPN) of the pancreas and pancreatic endocrine tumor. They found that characteristic morphological features and specific expressive ...
Mar 17, 2010 |
not rated yet |
0
Predicting prognosis and treatment response in a subset of pancreatic cancer patients
Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients ...
Feb 11, 2010 |
5 / 5 (1) |
0
Revealing cancers' weak spots: Researchers exploit genetic 'co-dependence' to kill treatment-resistant tumor cells
(PhysOrg.com) -- Cancer cells fueled by the mutant KRAS oncogene, which makes them notoriously difficult to treat, can be killed by blocking a more vulnerable genetic partner of KRAS, report scientists at ...
Oct 20, 2009 |
5 / 5 (1) |
1
Imaging features of intraductal papillary mucinous neoplasms of the pancreas
The intraductal papillary mucinous neoplasms (IPMN) can evolve through all biological stages, from slight dysplasia to carcinoma. As one of the few surgically curable pancreatic tumors, accurate preoperative prediction of ...
Sep 16, 2009 |
not rated yet |
0
